Cargando…

Intravitreally Injected Anti-VEGF Antibody Reduces Brown Fat in Neonatal Mice

Anti-vascular endothelial growth factor (VEGF) agents are the mainstay treatment for various angiogenesis-related retinal diseases. Currently, bevacizumab, a recombinant humanized anti-VEGF antibody, is trailed in retinopathy of prematurity, a vasoproliferative retinal disorder in premature infants....

Descripción completa

Detalles Bibliográficos
Autores principales:	Jo, Dong Hyun, Park, Sung Wook, Cho, Chang Sik, Powner, Michael B., Kim, Jin Hyoung, Fruttiger, Marcus, Kim, Jeong Hun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520452/ https://www.ncbi.nlm.nih.gov/pubmed/26226015 http://dx.doi.org/10.1371/journal.pone.0134308

Ejemplares similares

Intravitreal Injection of Anti-VEGF Antibody Induces Glomerular Endothelial Cells Injury
por: Touzani, F., et al.
Publicado: (2019)

Inflammatory Complications of Intravitreal Anti-VEGF Injections
por: Cox, Jacob T., et al.
Publicado: (2021)

Development of a patient-derived xenograft model of glioblastoma via intravitreal injection in mice
por: Lee, Jooyoung, et al.
Publicado: (2019)

Hypotony Maculopathy Related to Anti-VEGF Intravitreal Injection
por: Lima-Fontes, Mário, et al.
Publicado: (2022)

Current Evidence for the Prevention of Endophthalmitis in Anti-VEGF Intravitreal Injections
por: Lau, P. ET., et al.
Publicado: (2018)

Effect of a Single Intravitreal Bevacizumab Injection on Proteinuria in Patients With Diabetes
por: Chung, Yoo-Ri, et al.
Publicado: (2020)

Estimation of the need for bilateral intravitreal anti-VEGF injections in clinical practice
por: Giocanti-Auregan, Audrey, et al.
Publicado: (2016)

Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic
por: Korobelnik, Jean-François, et al.
Publicado: (2020)

The Association of Intravitreal Anti-VEGF Injections With Kidney Function in Diabetic Retinopathy
por: Bunge, Casey C., et al.
Publicado: (2023)

Detection of aqueous VEGF concentrations before and after intravitreal injection of anti-VEGF antibody using low-volume sampling paper-based ELISA
por: Hsu, Min-Yen, et al.
Publicado: (2016)

Brown Fat and Browning for the Treatment of Obesity and Related Metabolic Disorders
por: Kim, So Hun, et al.
Publicado: (2016)

Comparison of Systemic Adverse Events Associated with Intravitreal Anti-VEGF Injection: Ranibizumab versus Bevacizumab
por: Hwang, Duck Jin, et al.
Publicado: (2012)

Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections
por: Levin, Ariana M, et al.
Publicado: (2017)

Concentrations of VEGF and PlGF Decrease in Eyes After Intravitreal Conbercept Injection
por: Zhou, Jun, et al.
Publicado: (2018)

Use of Artificial Tears in Patients Undergoing Treatment with Anti-VEGF Intravitreal Injections
por: Pastor-Pascual, Francisco, et al.
Publicado: (2022)

Risk factors for breakthrough vitreous hemorrhage after intravitreal anti-VEGF injection in age-related macular degeneration with submacular hemorrhage
por: Shin, Yong-Il, et al.
Publicado: (2018)

Genome-wide association study of the response of patients with diabetic macular edema to intravitreal Anti-VEGF injection
por: Hong, Eun Hee, et al.
Publicado: (2022)

Observation of total VEGF level in hyperglycemic mouse eyes after intravitreal injection of the novel anti-VEGF drug conbercept
por: Du, Liping, et al.
Publicado: (2015)

Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics
por: Morioka, Masakazu, et al.
Publicado: (2020)

Intravitreal vascular endothelial growth factor (VEGF) inhibitor injection in patient during pregnancy
por: Kianersi, Farzan, et al.
Publicado: (2021)

Potential bias of preoperative intravitreal anti-VEGF injection for complications of proliferative diabetic retinopathy
por: Takayama, Kei, et al.
Publicado: (2021)

Hydrophilic Lens Opacification after Intravitreal Anti-VEGF Injections: A Case Series
por: Wahab, Charbel, et al.
Publicado: (2022)

Acute macular neuroretinopathy associated with intravitreal anti-VEGF injection: A case report
por: Radwan, Loubna M., et al.
Publicado: (2022)

Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
por: Bergamo, Vinicius Campos, et al.
Publicado: (2023)

Intraocular Distribution and Kinetics of Intravitreally Injected Antibodies and Nanoparticles in Rabbit Eyes
por: Kim, Hyeong Min, et al.
Publicado: (2020)

Neuropilin 1 Involvement in Choroidal and Retinal Neovascularisation
por: Fernández-Robredo, Patricia, et al.
Publicado: (2017)

Real-world incidence of endopthalmitis after intravitreal anti-VEGF injections in Korea: findings from the Common Data Model in ophthalmology
por: Mun, Yongseok, et al.
Publicado: (2021)

Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration
por: Davis, R Prince, et al.
Publicado: (2010)

Incidence of ocular hypertension after intravitreal injection of anti-VEGF agents in the treatment of neovascular AMD
por: Moraru, Andreea, et al.
Publicado: (2017)

Intraocular Pressure Elevation Following Intravitreal Anti-VEGF Injections: Short- and Long-term Considerations
por: Levin, Ariana M., et al.
Publicado: (2021)

Anti-VEGF intravitreal injections in the era of COVID-19: responding to different levels of epidemic pressure
por: Korobelnik, Jean-François, et al.
Publicado: (2021)

Clinical Features Associated with Acute Elevated Intraocular Pressure After Intravitreal Anti-VEGF Injections
por: LoBue, Stephen A, et al.
Publicado: (2023)

Clinical manifestations of intravitreal bortezomib injection
por: Nguyen, Chan, et al.
Publicado: (2020)

The remote effects of intravitreal anti-VEGF therapy
por: Balta, F, et al.
Publicado: (2016)

Issues with Intravitreal Administration of Anti-VEGF Drugs
por: Schargus, Marc, et al.
Publicado: (2020)

Global reported endophthalmitis risk following intravitreal injections of anti-VEGF: a literature review and analysis
por: Sigford, Douglas K, et al.
Publicado: (2015)

Endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive review
por: Merani, Rohan, et al.
Publicado: (2015)

Intravitreal injections of anti-VEGF agents and antibiotic prophylaxis for endophthalmitis: A systematic review and meta-analysis
por: Bande, Manuel F., et al.
Publicado: (2017)

Endophthalmitis rates among patients receiving intravitreal anti-VEGF injections: a USA claims analysis
por: Kiss, Szilárd, et al.
Publicado: (2018)

Retinal function determined by flicker ERGs before and soon after intravitreal injection of anti-VEGF agents
por: Terauchi, Gaku, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5v29e11u12i89m85n5an8klim8